Association of cardiovascular-kidney-metabolic syndrome with risk of hip/knee osteoarthritis: A prospective cohort study.

Authors

Zheng Ma, Yixiao Zhang, Liuxin Li, Gang Zheng, Honghao Yang, Ruiyao Zhang, Yuqian Li, Wenxu Wang, Chao Ji, Yang Xia, Yuhong Zhao

Published in

Maturitas. Volume 212. Pages 109056. Jul 17, 2026. Epub Jul 17, 2026.

Abstract

Cardiovascular-kidney-metabolic syndrome reflects the interplay of metabolic, renal, and cardiovascular dysfunction and is linked to adverse health outcomes. Its association with osteoarthritis remains unclear.
This prospective cohort study included 256,364 UK Biobank participants free of osteoarthritis at baseline. Cardiovascular-kidney-metabolic syndrome was classified into five stages (0-4) based on modified American Heart Association criteria. Genetic risk scores for hip/knee osteoarthritis were derived from established single nucleotide polymorphisms. Cox proportional hazards models were used to estimate hazard ratios and 95% confidence intervals for incident hip/knee osteoarthritis.
Over a median follow-up of 11.0 years, 8209 hip osteoarthritis and 12,729 knee osteoarthritis cases were identified. Higher cardiovascular-kidney-metabolic syndrome stages were associated with progressively increased risks of both outcomes. Compared with Stage 0, participants with Stage 4 had higher risks of hip osteoarthritis (hazard ratio 1.76, 95% confidence interval 1.58-1.95) and knee osteoarthritis (hazard ratio 2.67, 95% confidence interval 2.44-2.93). Associations were stronger in individuals <60 years and differed by sex: hip osteoarthritis risk was greater in men, while knee osteoarthritis risk was greater in women. Individuals with both high genetic susceptibility and Stage 4 cardiovascular-kidney-metabolic syndrome had the highest risks of hip osteoarthritis (hazard ratio 3.10, 95% confidence interval 2.60-3.70) and knee osteoarthritis (hazard ratio 4.00, 95% confidence interval 3.42-4.68). A positive additive interaction was observed between genetic susceptibility and cardiovascular-kidney-metabolic syndrome stage.
Our findings indicate that higher cardiovascular-kidney-metabolic syndrome stages are associated with increased hip/knee osteoarthritis risk, particularly in younger individuals.

PMID:
42470749
Bibliographic data and abstract were imported from PubMed on 19 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.